Preferred Label : Methylmalonic aciduria, cbla type;
Symbol : MACA;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Methylmalonic acidemia, cbla type; Methylmalonic aciduria, vitamin b12-responsive, due to defect in synthesis of adenosylcobalamin,
cbla type;
Description : Methylmalonic aciduria is a genetically heterogeneous disorder of methylmalonate and
cobalamin (cbl; vitamin B12) metabolism. Different forms of isolated methylmalonic
aciduria have been classified according to complementation groups of cells in vitro.
Patients with defects in the synthesis of AdoCbl are usually responsive to vitamin
B12 therapy and are classified as 'cbl' type: these include cblA and cblB (251110),
which is caused by mutation in the MMAB gene (607568) on 12q24. See also cblH (277410),
which may be a subset of cblA. The 'mut' form of MMA (251000) is caused by mutation
in the MUT gene on chromosome 6p. In general, the mut form of MMA is unresponsive
to vitamin B12 therapy. Combined methylmalonic aciduria and homocystinuria may be
seen in complementation groups cblC (277400), cblD (277410), cblF (277380), and cblJ
(614857).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the MMAA gene (MMAA, 607481.0001);
Laboratory abnormalities : Methylmalonic acidemia; Methylmalonic aciduria; Long-chain ketonuria; Hyperglycinemia; Hyperammonemia; Decreased adenosylcobalamin (AdoCbl); Normal serum cobalamin (vitamin B12); Decreased methylmalonyl-CoA mutase (MUT, 609058) activity;
Prefixed ID : #251100;
Origin ID : 251100;
UMLS CUI : C1855109;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
Not associated HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)